Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22

Oncogene volume 24, pages 5191–5197 (2005)Cite this article

Abstract

We analysed a complex translocation involving chromosomes 7, 11, 19 and 22 in infant acute monocytic leukemia, and identified that the MLL gene on 11q23 was fused to the unconventional myosin type 1F, MYO1F, gene on 19p13.2–13.3. MYO1F consists of at least 28 exons and was predicted to encode a 1098-amino-acid with an N-terminal head domain containing both ATP-binding and actin-binding sequences, a neck domain with a single IQ motif, and a tail with TH1, TH2 and SH3 domains. Northern blot analysis of RNAs prepared from multiple tissues showed that the expression of approximately 4-kb transcripts appeared constant in most tissues examined. However, MYO1F was expressed in only three of 22 leukemic cell lines. The MLL-MYO1F fusion protein contains almost the entire MYO1F, however, C-terminal MYO1F has neither the transactivation domain nor the dimerization domain found in various MLL fusion partners. Further analysis of this novel type of MLL fusion protein would provide new insights into leukemogenesis. MYO1F is the fourth partner gene of MLL on 19p13. At the cytogenetic level, it may be difficult to distinguish MLL-ENL, MLL-ELL, MLL-EEN and MLL-MYO1F fusions created by t(11;19)(q23;p13), and it is likely that cases of t(11;19) lacking a known fusion gene may result in this gene fusion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

Abbreviations

AML:

acute myeloid leukemia

ALL:

acute lymphoblastic leukemia

AMoL:

acute monocytic leukemia

RT–PCR:

reverse transcription–polymerase chain reaction

References

  • Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR and Korsmeyer SJ . (2002). Nat. Genet., 30, 41–47.

  • Beverloo HB, Le Coniat M, Wijsman J, Lillington DM, Bernard O, de Klein A, van Wering E, Welborn J, Young BD, Hagemeijer A and Hagemeijer A . (1995). Cancer Res., 55, 4220–4224.

  • Biondi A, Cimino G, Pieters R and Pui CH . (2000). Blood, 96, 24–33.

  • Bloomfield CD, Archer KJ, Mrozek K, Lillington DM, Kaneko Y, Head DR, Dal Cin P and Raimondi SC . (2002). Genes Chromosomes Cancer, 33, 362–378.

  • Chen AH, Stephan DA, Hasson T, Fukushima K, Nelissen CM, Chen AF, Jun AI, Ramesh A, Van Camp G and Smith RJ . (2001). Arch. Otolaryngol. Head Neck Surg., 127, 921–925.

  • Chinwalla V, Chien A, Odero M, Neilly MB, Zeleznik-Le NJ and Rowley JD . (2003). Oncogene, 22, 1400–1410.

  • Crozet F, el Amraoui A, Blanchard S, Lenoir M, Ripoll C, Vago P, Hamel C, Fizames C, Levi-Acobas F, Depetris D, Mattei MG, Weil D, Pujol R and Petit C . (1997). Genomics, 40, 332–341.

  • Daser A and Rabbitts TH . (2004). Genes Dev., 18, 965–974.

  • DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD and Cleary ML . (2002). Blood, 99, 3780–3785.

  • Eguchi M, Eguchi-Ishimae M and Greaves M . (2004). Blood, 103, 3876–3882.

  • Fu JF, Liang DC, Yang CP, Hsu JJ and Shih LY . (2003). Genes Chromosomes Cancer, 38, 253–259.

  • Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM and Canaani E . (1992). Cell, 71, 701–708.

  • Hasson T, Skowron JF, Gilbert DJ, Avraham KB, Perry WL, Bement WM, Anderson BL, Sherr EH, Chen Z-Y, Greene LA, Ward DC, Corey DP, Mooseker MS, Copeland NG and Jenkins NA . (1996). Genomics, 36, 431–439.

  • Hayashi Y . (2000). Semin. Hematol., 37, 368–380.

  • Hayashi Y . (2003). Int J. Hematol., 78, 414–420.

  • Hiwatari M, Taki T, Taketani T, Taniwaki M, Sugita K, Okuya M, Eguchi M and Hayashi Y . (2003). Oncogene, 22, 2851–2855.

  • Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL and Cleary ML . (1993). Blood, 81, 3197–3203.

  • Hsu K and Look AT . (2003). Cancer Cell, 4, 81–83.

  • Kawasaki H, Isoyama K, Eguchi M, Hibi S, Kinukawa N, Kosaka Y, Oda T, Oda M, Nishimura S, Imaizumi M, Okamura T, Hongo T, Okawa H, Mizutani S, Hayashi Y, Tsukimoto I, Kamada N and Ishii E . (2001). Blood, 98, 3589–3594.

  • Kosaka Y, Koh K, Kinukawa N, Wakazono Y, Isoyama K, Oda T, Hayashi Y, Ohta S, Moritake H, Oda M, Nagatoshi Y, Kigasawa H, Ishida Y, Ohara A, Hanada R, Sako M, Sato T, Mizutani S, Horibe K and Ishii E . (2004). Blood, 104, 3527–3534.

  • Lamant L, Gascoyne RD, Duplantier MM, Armstrong F, Raghab A, Chhanabhai M, Rajcan-Separovic E, Raghab J, Delsol G and Espinos E . (2003). Genes Chromosomes Cancer, 37, 427–432.

  • Lavau C, Szilvassy SJ, Slany R and Cleary ML . (1997). EMBO J., 16, 4226–4237.

  • Liu H, Chen B, Xiong H, Huang QH, Zhang QH, Wang ZG, Li BL, Chen Z and Chen SJ . (2004). Oncogene, 23, 3385–3394.

  • Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ and Collins FS . (1993). Science, 261, 1041–1044.

  • Look AT . (1997). Science, 278, 1059–1064.

  • Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S and Thirman MJ . (2001). Mol. Cell. Biol., 21, 5678–5687.

  • Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D, Brock HW, Slany R and Hess JL . (2003). Cancer Cell, 4, 197–207.

  • Megonigal MD, Rappaport EF, Wilson RB, Jones DH, Whitlock JA, Ortega JA, Slater DJ, Nowell PC and Felix CA . (2000). Proc. Natl. Acad. Sci. USA, 97, 9597–9602.

  • Mitani K, Kanda Y, Ogawa S, Tanaka T, Inazawa J, Yazaki Y and Hirai H . (1995). Blood, 85, 2017–2024.

  • Nishioka M, Kohno T, Tani M, Yanaihara N, Tomizawa Y, Otsuka A, Sasaki S, Kobayashi K, Niki T, Maeshima A, Sekido Y, Minna JD, Sone S and Yokota J . (2002). Proc. Natl. Acad. Sci. USA, 99, 12269–12274.

  • Oliver TN, Berg JS and Cheney RE . (1999). Cell. Mol. Life Sci., 56, 243–257.

  • Ono R, Taki T, Taketani T, Kawaguchi H, Taniwaki M, Okamura T, Kawa K, Hanada R, Kobayashi M and Hayashi Y . (2002a). Cancer Res., 62, 333–337.

  • Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H and Hayashi Y . (2002b). Cancer Res., 62, 4075–4080.

  • Rowley JD . (1998). Annu. Rev. Genet., 32, 495–519.

  • Shibuya N, Taki T, Mugishima H, Chin M, Tsuchida M, Sako M, Kawa K, Ishii E, Miura I, Yanagisawa M and Hayashi Y . (2001). Genes Chromosomes Cancer, 32, 1–10.

  • Shilatifard A, Lane WS, Jackson KW, Conaway RC and Conaway JW . (1996). Science, 271, 1873–1876.

  • Slater DJ, Hilgenfeld E, Rappaport EF, Shah N, Meek RG, Williams WR, Lovett BD, Osheroff N, Autar RS, Ried T and Felix CA . (2002). Oncogene, 21, 4706–4714.

  • Slany RK, Lavau C and Cleary ML . (1998). Mol. Cell Biol., 18, 122–129.

  • So CW, Caldas C, Liu MM, Chen SJ, Huang QH, Gu LJ, Sham MH, Wiedemann LM and Chan LC . (1997). Proc. Natl. Acad. Sci. USA, 94, 2563–2568.

  • So CW and Cleary ML . (2002). Mol. Cell. Biol., 22, 6542–6552.

  • So CW, Lin M, Ayton PM, Chen EH and Cleary ML . (2003). Cancer Cell, 4, 99–110.

  • Soldati T . (2003). Traffic, 4, 358–366.

  • Taketani T, Taki T, Ishii E, Hanada R, Tsuchida M, Sugita K, Sugita K and Hayashi Y . (2004). Blood, 103, 1085–1088.

  • Taki T, Hayashi Y, Taniwaki M, Seto M, Ueda R, Hanada R, Suzukawa K, Yokota J and Morishita K . (1996). Oncogene, 13, 2121–2130.

  • Thirman MJ, Levitan DA, Kobayashi H, Simon MC and Rowley JD . (1994). Proc. Natl. Acad. Sci. USA, 91, 12110–12114.

  • Tkachuk DC, Kohler S and Cleary ML . (1992). Cell, 71, 691–700.

  • Tsutsumi S, Taketani T, Nishimura K, Ge X, Taki T, Sugita K, Ishii E, Hanada R, Ohki M, Aburatani H and Hayashi Y . (2003). Cancer Res., 63, 4882–4887.

  • Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa III R, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD and Diaz MO . (1991). Proc. Natl. Acad. Sci. USA, 88, 10735–10739.

Download references

Acknowledgements

We thank Dr Yoshinobu Matsuo (Hayashibara Biochemical Laboratories, Inc., Fujisaki Cell Center, Okayama, Japan) for providing varieties of leukemic cell lines. This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan, a Grant-in-Aid for Scientific Research on Priority Areas, a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japan Leukaemia Research Fund.

Author information

Authors and Affiliations

  1. Department of Molecular Laboratory Medicine, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kajii-cho Kawaramachi-Hirokoji, Kamigyo-ku, 602-8566, Kyoto, Japan

    Tomohiko Taki & Masafumi Taniwaki

  2. Department of Pediatrics and Institute of DNA Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan

    Masaharu Akiyama, Shinobu Saito, Yoko Kato, Yuki Yuza & Yoshikatsu Eto

  3. Division of Hematopoietic Factors, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan

    Ryoichi Ono

  4. Division of Hematology/Oncology, Gunma Children's Medical Center, 779 Shimohakoda, Kitatachibana, 377-8577, Gunma, Japan

    Yasuhide Hayashi

Authors
  1. Tomohiko Taki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaharu Akiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shinobu Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryoichi Ono
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masafumi Taniwaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoko Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuki Yuza
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshikatsu Eto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yasuhide Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuhide Hayashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taki, T., Akiyama, M., Saito, S. et al. The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22. Oncogene 24, 5191–5197 (2005). https://doi.org/10.1038/sj.onc.1208711

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208711

Keywords

This article is cited by

Search

Advanced search

Quick links